title: Nuedexta for the Treatment of Pseudobulbar Affect: Estimating the Financial Impact to the Scottish NHS.
authors.affiliation: ICON Health Economics, Oxford, UK.
authors.forename: C
authors.initials: C
authors.lastname: Kiff
authors.affiliation: ICON Health Economics, Oxford, UK.
authors.forename: S
authors.initials: S
authors.lastname: Mealing
authors.affiliation: ICON Health Economics, Oxford, UK.
authors.forename: M
authors.initials: M
authors.lastname: Singh
authors.affiliation: ICON Health Economics, Oxford, UK.
authors.forename: S
authors.initials: S
authors.lastname: Baculea
authors.affiliation: ICON Health Economics, Oxford, UK.
authors.forename: A
authors.initials: A
authors.lastname: Badhan
authors.affiliation: Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
authors.forename: C
authors.initials: C
authors.lastname: Yonan